Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$0.64 - $0.78 $1,496 - $1,824
-2,339 Reduced 36.73%
4,029 $3,000
Q4 2023

Feb 15, 2024

SELL
$0.68 - $2.39 $20,329 - $71,451
-29,896 Reduced 82.44%
6,368 $4,000
Q3 2023

Nov 14, 2023

BUY
$2.15 - $3.64 $3,547 - $6,006
1,650 Added 4.77%
36,264 $77,000
Q2 2023

Aug 14, 2023

BUY
$3.17 - $5.82 $57,969 - $106,430
18,287 Added 112.0%
34,614 $117,000
Q1 2023

May 15, 2023

BUY
$3.94 - $7.05 $2,497 - $4,469
634 Added 4.04%
16,327 $64,000
Q4 2022

Feb 14, 2023

BUY
$4.7 - $9.98 $5,442 - $11,556
1,158 Added 7.97%
15,693 $80,000
Q3 2022

Nov 14, 2022

BUY
$4.13 - $8.79 $6,641 - $14,134
1,608 Added 12.44%
14,535 $114,000
Q2 2022

Aug 22, 2022

BUY
$3.26 - $7.06 $1,131 - $2,449
347 Added 2.76%
12,927 $50,000
Q1 2022

May 16, 2022

BUY
$6.75 - $13.52 $850 - $1,703
126 Added 1.01%
12,580 $85,000
Q3 2021

Nov 15, 2021

BUY
$16.97 - $25.06 $119,214 - $176,046
7,025 Added 129.4%
12,454 $312,000
Q2 2021

Aug 12, 2021

BUY
$19.44 - $25.06 $30,929 - $39,870
1,591 Added 41.45%
5,429 $107,000
Q1 2021

May 17, 2021

BUY
$20.81 - $45.5 $22,079 - $48,275
1,061 Added 38.21%
3,838 $90,000
Q4 2020

Feb 12, 2021

BUY
$23.94 - $46.81 $18,242 - $35,669
762 Added 37.82%
2,777 $106,000
Q3 2020

Nov 13, 2020

BUY
$21.05 - $42.7 $42,415 - $86,040
2,015 New
2,015 $55,000

Others Institutions Holding ALVR

About Allovir, Inc.


  • Ticker ALVR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 93,063,400
  • Market Cap $933M
  • Description
  • Allovir, Inc., a clinical-stage cell therapy company, engages in the research and development of allogeneic, off-the-shelf multi-virus specific T cell (VST) therapies to prevent and treat devastating viral-associated diseases. The company's lead product is posoleucel, an allogeneic, off-the-shelf VST therapy, to treat BK virus, cytomegalovirus, ...
More about ALVR
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.